Variant report
Variant | nsv1042369 |
---|---|
Chromosome Location | chr11:23817905-23848437 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:40)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:5)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:40 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr11:23829111-23829319 | K562 | blood: | n/a | chr11:23829233-23829244 |
2 | CEBPB | chr11:23829094-23829349 | A549 | lung: | n/a | chr11:23829233-23829244 |
3 | CEBPB | chr11:23820809-23821124 | HepG2 | liver: | n/a | chr11:23821104-23821117 |
4 | CEBPB | chr11:23820766-23821130 | IMR90 | lung: | n/a | chr11:23821104-23821117 |
5 | CEBPB | chr11:23844250-23844479 | IMR90 | lung: | n/a | chr11:23844394-23844405 |
6 | CEBPB | chr11:23829075-23829384 | HepG2 | liver: | n/a | chr11:23829233-23829244 |
7 | CEBPB | chr11:23844303-23844514 | HepG2 | liver: | n/a | chr11:23844394-23844405 |
8 | CEBPB | chr11:23820772-23821109 | A549 | lung: | n/a | n/a |
9 | CEBPB | chr11:23829064-23829390 | IMR90 | lung: | n/a | chr11:23829233-23829244 |
10 | CTCF | chr11:23827236-23827314 | ProgFib | skin: | n/a | n/a |
11 | E2F4 | chr11:23825851-23826211 | MCF10A-Er-Src | breast: | n/a | n/a |
12 | EP300 | chr11:23831012-23831466 | SK-N-SH_RA | brain: | n/a | n/a |
13 | EP300 | chr11:23831030-23831481 | SK-N-SH_RA | brain: | n/a | n/a |
14 | GATA3 | chr11:23831175-23831759 | SH-SY5Y | brain: | n/a | n/a |
15 | GATA3 | chr11:23823719-23823970 | SH-SY5Y | brain: | n/a | n/a |
16 | JUN | chr11:23841508-23841762 | HepG2 | liver: | n/a | chr11:23841640-23841653 chr11:23841641-23841650 |
17 | JUND | chr11:23820396-23820606 | HepG2 | liver: | n/a | n/a |
18 | JUND | chr11:23840391-23840591 | HepG2 | liver: | n/a | n/a |
19 | JUND | chr11:23841496-23841802 | HepG2 | liver: | n/a | chr11:23841641-23841650 |
20 | MAFK | chr11:23823403-23823581 | IMR90 | lung: | n/a | n/a |
21 | MAFK | chr11:23819607-23819735 | HepG2 | liver: | n/a | chr11:23819693-23819704 chr11:23819692-23819706 chr11:23819689-23819705 chr11:23819694-23819705 chr11:23819694-23819705 |
22 | MAFK | chr11:23819589-23819801 | HepG2 | liver: | n/a | chr11:23819693-23819704 chr11:23819692-23819706 chr11:23819689-23819705 chr11:23819694-23819705 chr11:23819694-23819705 |
23 | MXI1 | chr11:23828886-23828951 | K562 | blood: | n/a | n/a |
24 | MYC | chr11:23817917-23817994 | MCF10A-Er-Src | breast: | n/a | n/a |
25 | MYC | chr11:23843471-23843496 | H1-hESC | embryonic stem cell: | n/a | n/a |
26 | NR3C1 | chr11:23843986-23844197 | A549 | lung: | n/a | n/a |
27 | POLR2A | chr11:23829546-23829746 | MCF10A-Er-Src | breast: | n/a | n/a |
28 | POLR2A | chr11:23838371-23838383 | A549 | lung: | n/a | n/a |
29 | POLR2A | chr11:23838241-23838338 | A549 | lung: | n/a | n/a |
30 | POLR2A | chr11:23818661-23818698 | MCF10A-Er-Src | breast: | n/a | n/a |
31 | POLR2A | chr11:23830339-23830369 | MCF10A-Er-Src | breast: | n/a | n/a |
32 | POLR2A | chr11:23828297-23828385 | MCF10A-Er-Src | breast: | n/a | n/a |
33 | POLR2A | chr11:23826694-23826969 | MCF10A-Er-Src | breast: | n/a | n/a |
34 | POLR2A | chr11:23828623-23828772 | MCF10A-Er-Src | breast: | n/a | n/a |
35 | POLR2A | chr11:23823187-23823365 | MCF10A-Er-Src | breast: | n/a | n/a |
36 | RAD21 | chr11:23830994-23831379 | SK-N-SH_RA | brain: | n/a | n/a |
37 | RAD21 | chr11:23831262-23831442 | SK-N-SH_RA | brain: | n/a | n/a |
38 | SPI1 | chr11:23826478-23826682 | GM12891 | blood: | n/a | chr11:23826596-23826609 |
39 | STAT3 | chr11:23828915-23828947 | MCF10A-Er-Src | breast: | n/a | n/a |
40 | STAT3 | chr11:23822530-23822787 | MCF10A-Er-Src | breast: | n/a | n/a |
No data |
(count:2 , 50 per page) page:
1
(count:5 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-LUZP2-1 | chr11:23818254-23818516 | ENSG00000255193 |
2 | lnc-RP11-17A1.2.1-2 | chr11:23826025-23826144 | ENSG00000254861 |
3 | lnc-RP11-17A1.2.1-5 | chr11:23818256-23819005 | NONHSAT018430 |
4 | lnc-RP11-17A1.2.1-2 | chr11:23829736-23829778 | XLOC_009395 |
5 | lnc-RP11-17A1.2.1-2 | chr11:23826000-23826222 | XLOC_009395 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000254861 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs539827956 | chr11:23817917-23817918 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs545176256 | chr11:23817992-23817993 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs565342147 | chr11:23818014-23818015 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs189564563 | chr11:23818016-23818017 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs376027206 | chr11:23818039-23818040 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs565028223 | chr11:23818047-23818048 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs532123291 | chr11:23818049-23818050 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs192427531 | chr11:23818081-23818082 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs561242315 | chr11:23818084-23818085 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs184760442 | chr11:23818130-23818131 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs188827165 | chr11:23818153-23818154 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs1528559 | chr11:23818156-23818157 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs532692228 | chr11:23818206-23818207 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs552003483 | chr11:23818221-23818222 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs181554356 | chr11:23818240-23818241 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs537525632 | chr11:23818257-23818258 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
17 | rs554178167 | chr11:23818268-23818269 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
18 | rs567711374 | chr11:23818292-23818293 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
19 | rs533884364 | chr11:23818314-23818315 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
20 | rs550515003 | chr11:23818315-23818316 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
21 | rs148446220 | chr11:23818318-23818319 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
22 | rs74570182 | chr11:23818322-23818323 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
23 | rs558803638 | chr11:23818339-23818340 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
24 | rs186328219 | chr11:23818349-23818350 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
25 | rs189524754 | chr11:23818359-23818360 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
26 | rs544699902 | chr11:23818432-23818433 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
27 | rs73423757 | chr11:23818479-23818480 | Weak transcription | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs574883485 | chr11:23818500-23818501 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
29 | rs540571591 | chr11:23818548-23818549 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
30 | rs560796066 | chr11:23818639-23818640 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
31 | rs567048844 | chr11:23818652-23818653 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
32 | rs532619364 | chr11:23818675-23818676 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
33 | rs552767359 | chr11:23818682-23818683 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
34 | rs562727347 | chr11:23818700-23818701 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
35 | rs181599597 | chr11:23818757-23818758 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
36 | rs527712767 | chr11:23818772-23818773 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
37 | rs185875720 | chr11:23818786-23818787 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
38 | rs567723704 | chr11:23818823-23818824 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
39 | rs80279703 | chr11:23818832-23818833 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
40 | rs552273346 | chr11:23818847-23818848 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
41 | rs547392881 | chr11:23818848-23818849 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
42 | rs189994565 | chr11:23818969-23818970 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
43 | rs183272307 | chr11:23819047-23819048 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs4514410 | chr11:23819111-23819112 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs151022486 | chr11:23819113-23819114 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs140878434 | chr11:23819129-23819130 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs556424360 | chr11:23819132-23819133 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs576292907 | chr11:23819170-23819171 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs186507347 | chr11:23819202-23819203 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs376595280 | chr11:23819263-23819264 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Burkitt''s lymphoma | 19759907 | CNVD |
Breast cancer | 17603634 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Melanoma | 18172304 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Wilms tumour | 21544195 | CNVD |
Parathyroid adenoma | 22454399 | CNVD |
Chordoma | 21602918 | CNVD |
Breast cancer | 21949216 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 19222835 | CNVD |
T-cell acute lymphoblastic leukemia | 20065082 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Beckwith-Wiedemann syndrome | 21518781 | CNVD |
Wilms tumour | 21518781 | CNVD |
Hepatoblastoma | 21518781 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Gastric cancer | 17908304 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Autism | 22495311 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21785460 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Medulloblastoma | 16783165 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Congenital diaphragmatic hernia | 21525063 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Potocki-Shaffer syndrome | 19222835 | CNVD |
WAGR syndrome | 19222835 | CNVD |
Chordoma | 18071362 | CNVD |
Autism | 22102821 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Breast cancer | 21364760 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Breast cancer | 22522925 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:23812200-23818600 | Weak transcription | Rectal Mucosa Donor 31 | rectum |
2 | chr11:23818600-23819400 | Enhancers | Rectal Mucosa Donor 31 | rectum |
3 | chr11:23818600-23820800 | Enhancers | Colon Smooth Muscle | Colon |
4 | chr11:23819400-23819800 | Weak transcription | Rectal Mucosa Donor 31 | rectum |
5 | chr11:23819600-23820000 | Enhancers | Stomach Mucosa | stomach |
6 | chr11:23819800-23820600 | Enhancers | Rectal Mucosa Donor 31 | rectum |
7 | chr11:23819800-23821000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
8 | chr11:23820200-23820600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
9 | chr11:23820400-23820800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
10 | chr11:23820400-23821000 | Enhancers | Rectal Smooth Muscle | rectum |
11 | chr11:23820800-23828200 | Weak transcription | Colon Smooth Muscle | Colon |
12 | chr11:23821000-23822600 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
13 | chr11:23822600-23823400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
14 | chr11:23823600-23824200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
15 | chr11:23826200-23826800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
16 | chr11:23828200-23828600 | Enhancers | Colon Smooth Muscle | Colon |
17 | chr11:23829600-23834800 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
18 | chr11:23848000-23848800 | Enhancers | Fetal Lung | lung |